Cancer Patients' Prehospital Emergency Care: Post Hoc Analysis from the French Prospective Multicenter Study EPICANCER.
cancer
emergency
malignancy
oncology
prehospital
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
09 Mar 2021
09 Mar 2021
Historique:
received:
25
01
2021
revised:
03
03
2021
accepted:
05
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
Very little data are available concerning the prehospital emergency care of cancer patients. The objective of this study is to report the trajectories and outcomes of cancer patients attended by prehospital emergency services. This was an ancillary study from a three-day cross-sectional prospective multicenter study in France. Adult patients with cancer were included if they called the emergency medical dispatch center Service d'Aide Médicale Urgente (SAMU). The study was registered on ClinicalTrials.gov (NCT03393260, accessed on 8th January 2018). During the study period, 1081 cancer patients called the SAMU. The three most frequent reasons were dyspnea (20.2%), neurological disorder (15.4%), and fatigue (13.1%). Among those patients, 949 (87.8%) were directed to the hospital, among which 802 (90.8%) were directed to an emergency department (ED) and 44 (5%) were transported directly to an intensive care unit (ICU). A mobile intensive care unit (MICU) was dispatched 213 (31.6%) times. The decision to dispatch an MICU seemed generally based on the patient's reason for seeking emergency care and the presence of severity signs rather than on the malignancy or the patient general health status. Among the patients who were directed to the ED, 98 (16.1%) were deceased on day 30. Mortality was 15.4% for those patients directed to the ED but who were not admitted to the ICU in the next 7 days, 28.2% for those who were admitted to ICU in the next 7 days, and 56.1% for those patients transported by the MICU directly to the ICU. Cancer patients attending prehospital emergency care were most often directed to EDs. Patients who were directly transported to the ICU had a high mortality rate, raising the question of improving triage policies.
Sections du résumé
BACKGROUND
BACKGROUND
Very little data are available concerning the prehospital emergency care of cancer patients. The objective of this study is to report the trajectories and outcomes of cancer patients attended by prehospital emergency services.
METHODS
METHODS
This was an ancillary study from a three-day cross-sectional prospective multicenter study in France. Adult patients with cancer were included if they called the emergency medical dispatch center Service d'Aide Médicale Urgente (SAMU). The study was registered on ClinicalTrials.gov (NCT03393260, accessed on 8th January 2018).
RESULTS
RESULTS
During the study period, 1081 cancer patients called the SAMU. The three most frequent reasons were dyspnea (20.2%), neurological disorder (15.4%), and fatigue (13.1%). Among those patients, 949 (87.8%) were directed to the hospital, among which 802 (90.8%) were directed to an emergency department (ED) and 44 (5%) were transported directly to an intensive care unit (ICU). A mobile intensive care unit (MICU) was dispatched 213 (31.6%) times. The decision to dispatch an MICU seemed generally based on the patient's reason for seeking emergency care and the presence of severity signs rather than on the malignancy or the patient general health status. Among the patients who were directed to the ED, 98 (16.1%) were deceased on day 30. Mortality was 15.4% for those patients directed to the ED but who were not admitted to the ICU in the next 7 days, 28.2% for those who were admitted to ICU in the next 7 days, and 56.1% for those patients transported by the MICU directly to the ICU.
CONCLUSION
CONCLUSIONS
Cancer patients attending prehospital emergency care were most often directed to EDs. Patients who were directly transported to the ICU had a high mortality rate, raising the question of improving triage policies.
Identifiants
pubmed: 33803366
pii: jcm10051145
doi: 10.3390/jcm10051145
pmc: PMC7967166
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT03393260']
Types de publication
Journal Article
Langues
eng
Références
Support Care Cancer. 2009 Dec;17(12):1499-506
pubmed: 19319576
Blood Rev. 2015 Nov;29(6):359-67
pubmed: 25998991
Am J Emerg Med. 2016 Oct;34(10):1934-1938
pubmed: 27412915
Intensive Care Med. 2018 Dec;44(12):2315-2318
pubmed: 30421252
Support Care Cancer. 2012 Aug;20(8):1589-99
pubmed: 22526151
J Clin Oncol. 2011 Jul 1;29(19):2683-8
pubmed: 21606431
N Engl J Med. 2018 Dec 20;379(25):2438-2450
pubmed: 30575480
Emerg Med Clin North Am. 2018 Aug;36(3):637-643
pubmed: 30037449
Ann Emerg Med. 2015 Jul;66(1):13A-15A
pubmed: 26305005
Am J Emerg Med. 2018 Nov;36(11):2038-2043
pubmed: 29573899
Prehosp Emerg Care. 2020 Nov-Dec;24(6):813-821
pubmed: 31961753
JAMA Oncol. 2017 Oct 12;3(10):e172450
pubmed: 28859189
J Clin Med. 2020 May 17;9(5):
pubmed: 32429507
J Clin Oncol. 2013 Aug 1;31(22):2810-8
pubmed: 23752112
Intensive Care Med. 2019 Jul;45(7):977-987
pubmed: 31143998
Support Care Cancer. 2010 Oct;18(10):1287-92
pubmed: 19813029
J Crit Care. 2020 Jun;57:36-41
pubmed: 32032902
Ann Emerg Med. 2016 Dec;68(6):706-711
pubmed: 26921969
Anticancer Res. 2018 Nov;38(11):6387-6391
pubmed: 30396962
J Clin Oncol. 2016 Sep 20;34(27):3315-24
pubmed: 27432921
J Clin Oncol. 2005 Jul 1;23(19):4406-13
pubmed: 15994150
Support Care Cancer. 2016 Mar;24(3):1251-60
pubmed: 26306522
Ann Intensive Care. 2019 Oct 2;9(1):110
pubmed: 31578641
Leuk Lymphoma. 2012 Jul;53(7):1352-9
pubmed: 22233111